PIPRA AG (short for Pre-Interventional Preventive Risk Assessment) is developing a cutting-edge AI-based pre-operative test to assess patient's risk of suffering from cognitive disorders after a surgery. |
LATEST NEWS
PIPRA wins pitch at the Oxford Saïd Entrepreneurship Forum.
PIPRA wins 1st Brain Innovation Award Read more
PIPRA has been chosen for the "Samsung for Impact Accelerator Program 2020"
Read more on startupticker |
“PIPRA will be a huge advancement compared to what we are doing now. If we get a score, or any kind of measurement, which will distinguish between those people at risk and those who are not at risk - this will be tremendously helpful."Dr. med. Henry Perschak, Head of the International Medical Center, Klinik Hirslanden Zurich |
“PIPRA represents exactly what I imagine an innovative start-up to be: They transform a challenging visionary idea - with a lot of passion and a highly motivated team - into a product that brings a clear added value for the society. This is what highly motivates me to engage in the Advisory Board."
Dr. sc. Techn. Christof A. Bühler, SCS Super Computing Systems
|